LanroNET, a non-interventional, prospective study to assess the resource utilization and cost of lanreotide autogel 120 mg in Polish patients with neuroendocrine tumors – results of interim analysis

AIM OF THE STUDY: To examine characteristics and treatment patterns of symptomatic neuroendocrine tumors (NETs) patients who received lanreotide Autogel 120 mg (ATG120) administered as part of routine clinical practice. MATERIAL AND METHODS: Lanro-NET is a national, multicenter, non-interventional,...

Descripción completa

Detalles Bibliográficos
Autores principales: Orlewska, Ewa, Bednarczuk, Tomasz, Kaminski, Grzegorz, Kos-Kudla, Beata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2014
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4355663/
https://www.ncbi.nlm.nih.gov/pubmed/25784845
http://dx.doi.org/10.5114/wo.2014.47908

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4355663/
https://www.ncbi.nlm.nih.gov/pubmed/25784845
http://dx.doi.org/10.5114/wo.2014.47908

Ejemplares similares